<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
RLAY
Relay Therapeutics
$
()


  • Relay Therapeutics price target lowered by $3 at JMP Securities, here's why

    7/18/2024 - 05:51am
  • Relay Therapeutics price target lowered by $2 at H.C. Wainwright, here's why

    7/17/2024 - 06:12am
  • Relay Therapeutics announces termination of license agreement with Genentech

    7/16/2024 - 16:20pm
  • Relay Therapeutics to explore RLY-2608 outside of cancer, says Oppenheimer

    6/6/2024 - 15:21pm
  • Relay Therapeutics expects cash to fund operations into second half of 2026

    6/6/2024 - 07:07am
  • Relay Therapeutics announces anticipated milestones

    6/6/2024 - 07:06am
  • Relay Therapeutics discloses three new programs at New Program & Platform event

    6/6/2024 - 07:06am
  • Fly Intel: After-Hours Movers

    6/5/2024 - 18:05pm
  • Relay teams with with Pfizer for RLY-2608/atirmociclib combo evaluation for BC

    6/5/2024 - 16:13pm
  • Relay Therapeutics to host New Program and Platform event

    5/13/2024 - 08:32am
  • Relay Therapeutics just upgraded at Barclays, here's why

    5/10/2024 - 04:45am
  • Relay Therapeutics price target lowered by $8 at Oppenheimer, here's why

    5/5/2024 - 17:49pm
  • Relay Therapeutics reports Q1 EPS (62c), consensus (71c)

    5/2/2024 - 16:47pm
  • Relay Therapeutics price target lowered by $2 at BofA, here's why

    2/27/2024 - 06:46am
  • Relay Therapeutics price target raised by $3 at H.C. Wainwright, here's why

    2/26/2024 - 06:10am
dynamic_feed Breaking News